Continuous practice of Yoga and meditation can help one to reduce the need for healthcare services by 43%, says a new study by Harvard-affiliated Massachusetts General Hospital Institute for Technology Assessment and the Benson-Henry Institute.
Doctors, patients and insurers have been struggling with how to determine who should be treated for hepatitis C now that effective but wildly expensive drugs can all but cure the disease. Treating prison inmates is a good investment that would save money in the long run, a study finds.
(HealthDay)—For patients with resistant hypertension (RH), computed tomography (CT) scanning followed by adrenal venous sampling (AVS) is a cost-effective screen for primary aldosteronism (PA), according to a study published online Nov. 10 in Circulation: Cardiovascular Quality and Outcomes.
SAN FRANCISCO — Despite powerful new medications, the lack of screening and treatment capacity will make it difficult to eliminate the hepatitis C virus in the United States, according to projections presented here at the Liver Meeting 2015.
Current trends show that even after 2020, more than 500,000 people will be unaware that they are infected with hepatitis C, said Jagpreet Chhatwal, PhD, from the Massachusetts General Hospital and Harvard Medical School in Boston.
Data are limited on outcomes of laparoscopic hysterectomy with morcellation in patients with unsuspected uterine sarcomas, which complicates discussions between physicians and patients about management of uterine fibroids. A shared clinical decision tool described in an article published in the European Journal of Obstetrics and Gynecology and Reproductive Biology may help in counseling patients about optimal management of large fibroids while taking into consideration risks and benefits as mandated by the Food and Drug Administration.